Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
44
ZVRA Quote, Financials, Valuation and Earnings
Last price:
$8.49
Seasonality move
:
-0.81%
Day range:
$8.34 - $8.83
52-week range:
$4.20 - $9.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.75x
P/B ratio:
6.50x
Volume:
2.5M
Avg. volume:
645.5K
1-year change:
78.93%
Market cap:
$453.2M
Revenue:
$27.5M
EPS (TTM):
-$2.11
Earnings Data
Next earnings date for ZVRA
Mar 28
2025
Most recent earnings per share
-$0.69
Missed by $0.28
(Nov 12/2024)
Consensus Estimate
-$0.41
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZVRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/28/2025 | Q4 | $8.8M | -- | -- | -$0.40 | -- |
| 11/12/2024 | Q3 | $4.9M | $3.7M | -$0.69 | -$0.41 | -$0.28 |
| 08/13/2024 | Q2 | $4.4M | $4.4M | -$0.48 | -$0.44 | -$0.04 |
| 05/08/2024 | Q1 | $3.8M | $3.4M | -$0.40 | -$0.48 | $0.08 |
| 03/28/2024 | Q4 | $11.7M | $12.9M | -$0.54 | -$0.27 | -$0.27 |
| 11/07/2023 | Q3 | $3.4M | $2.9M | -$0.30 | -$0.30 | -$0.00 |
| 08/14/2023 | Q2 | $3M | $8.5M | -$0.08 | -$0.34 | $0.26 |
| 05/15/2023 | Q1 | $2.7M | $3.2M | -$0.38 | -$0.23 | -$0.15 |
| 03/07/2023 | Q4 | $3.1M | $2M | $0.16 | -$0.18 | $0.34 |
| 11/09/2022 | Q3 | -- | $2.9M | -$0.19 | -- | -- |
| 06/30/2022 | Q2 | -- | $1.3M | -$0.70 | -- | -- |
| 03/31/2022 | Q1 | -- | $4M | -$0.05 | -- | -- |
| 12/31/2021 | Q4 | -- | $2.6M | $0.05 | -- | -- |
| 09/30/2021 | Q3 | -- | $2M | -$0.05 | -- | -- |
| 06/30/2021 | Q2 | -- | $12M | -$0.40 | -- | -- |
| 03/31/2021 | Q1 | -- | $12.1M | -$2.49 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.4M | -$1.13 | -- | -- |
| 09/30/2020 | Q3 | -- | $1.9M | -$0.68 | -- | -- |
| 06/30/2020 | Q2 | -- | $6.9M | $0.21 | -- | -- |
| 03/31/2020 | Q1 | -- | $2.1M | -$1.92 | -- | -- |
| 12/31/2019 | Q4 | -- | $1.4M | -$2.83 | -- | -- |
| 09/30/2019 | Q3 | -- | $11.5M | $0.96 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$5.28 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$7.36 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $2.88 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$15.04 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$14.56 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$28.32 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$11.52 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$10.88 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$7.04 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$17.76 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$10.88 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$14.72 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $9.28 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$3.20 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$10.24 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$10.88 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$39.20 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$7.77 | -- | -- |
| 12/31/2014 | Q4 | -- | -- | -$15.39 | -- | -- |
Zevra Therapeutics Earnings Questions
-
How Much did Zevra Therapeutics Generate in Revenue Last Quarter?
Zevra Therapeutics reported $3.7M worth of top line sales in its most recent quarter.
-
Did Zevra Therapeutics Beat Earnings Last Quarter?
Zevra Therapeutics announced earnings per share of -$0.69 which represents a miss of analyst forecast a -$0.41 per share.
-
Is Zevra Therapeutics Profitable?
Zevra Therapeutics reported $1.4M that represents $0.03 per share over the last quarter.
-
What is the Analyst Consensus for Zevra Therapeutics EPS Next Year?
Zevra Therapeutics's earnings are forecast to decrease from -$1.30 per share to -$1.18 per share next year representing a decrease of -49.01%.
-
When is Zevra Therapeutics's Earnings Date?
Zevra Therapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
